MARCOS
GONZÁLEZ DÍAZ
Investigador no período 1993-2023
MARÍA CONSUELO DEL
CAÑIZO FERNÁNDEZ-ROLDÁN
Investigadora no período 1993-2017
Publicacións nas que colabora con MARÍA CONSUELO DEL CAÑIZO FERNÁNDEZ-ROLDÁN (44)
2017
-
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
Leukemia, Vol. 31, Núm. 10, pp. 2094-2103
2016
2014
-
Late differentiation syndrome in acute promyelocytic leukemia: A challenging diagnosis
Hematology Reports, Vol. 6, Núm. 4, pp. 75-77
-
Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome
Leukemia Research, Vol. 38, Núm. 5, pp. 551-556
2012
-
Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients
Haematologica, Vol. 97, Núm. 8, pp. 1218-1224
2009
2002
-
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation
Leukemia, Vol. 16, Núm. 8, pp. 1423-1431
2001
2000
-
Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastic anaemia
British Journal of Haematology, Vol. 109, Núm. 3, pp. 658-660
-
Cerebral toxoplasmosis and Guillain-Barre syndrome after allogeneic peripheral stem cell transplantation
Transplant Infectious Disease, Vol. 2, Núm. 3, pp. 145-149
1999
-
Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation
Bone Marrow Transplantation, Vol. 24, Núm. 12, pp. 1279-1283
-
Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL
British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705
1998
-
Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation
Transfusion, Vol. 38, Núm. 4, pp. 385-391
-
Recuperación inmune tras trasplante autólogo de células progenitoras hemopoyéticas. Comparación entre células progenitoras de sangre periférica y de médula ósea
Medicina Clinica, Vol. 110, Núm. 20, pp. 768-773
1997
-
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas
Annals of Hematology, Vol. 74, Núm. 2, pp. 79-82
-
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors
Bone Marrow Transplantation, Vol. 20, Núm. 6, pp. 451-458
-
Minimal number of circulating CD34+ cells to assure successful leukapheresis and engraftment in peripheral blood progenitor cell transplantation
Infusionstherapie und Transfusionsmedizin, Vol. 24, Núm. 4, pp. 234
1996
-
A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation
British Journal of Haematology, Vol. 94, Núm. 1, pp. 140-147
1995
-
Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease
Leukemia, Vol. 9, Núm. 11, pp. 1896-1901
1994
-
The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML
Annals of Hematology, Vol. 68, Núm. 5, pp. 233-236